Varicella, MRSA, and Epidemiology: Healthcare Infection Control
This paper examines three interconnected healthcare topics: the management of varicella zoster (chickenpox) exposure in a pregnant registered nurse, including breakthrough varicella, immunoglobulin prophylaxis, and infection control protocols; the identification, treatment, and signs of methicillin-resistant Staphylococcus aureus (MRSA) infections; and core epidemiological concepts such as incidence, prevalence, endemic, epidemic, and pandemic disease patterns. Drawing on sources from the CDC, Immunization Action Coalition, and peer-reviewed literature, the paper provides a practical overview of how healthcare settings should respond to these infectious disease challenges.
- Varicella Zoster in Pregnancy and Breakthrough Varicella: Pregnant RN develops chickenpox despite immunoglobulin injection
- Infection Transmission Risks and Vaccination Considerations: Risks of varicella transmission from mother to infant
- Infection Control Measures for Varicella in Healthcare Settings: Six infection control issues raised by varicella case
- MRSA: Overview, Treatment, and Wound Care: MRSA management, wound care, and antibiotic treatment
- Signs and Symptoms of MRSA Infection: Clinical presentation of MRSA from mild to severe
- Epidemiological Concepts: Incidence and Prevalence: Definitions and distinctions between incidence and prevalence
- Endemic, Epidemic, and Pandemic Disease Patterns: Distinguishing endemic, epidemic, and pandemic disease spread
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Applies authoritative sources — CDC, Immunization Action Coalition, and peer-reviewed nursing literature — to support each clinical claim, lending credibility to practical recommendations.
- Organizes content into clearly delineated parts (A, B, C) that move logically from a specific case study to general disease-management principles and broader epidemiological theory.
- Balances clinical specificity (e.g., acyclovir use, negative airflow isolation, wound drainage procedures) with accessible explanations suitable for a healthcare audience.
Key academic technique demonstrated
The paper uses case-based reasoning to bridge theoretical knowledge and practical application. It opens with a specific clinical scenario — a pregnant RN exposed to varicella — and extracts generalizable infection control lessons from it, a technique common in nursing and allied health academic writing that grounds abstract guidelines in real-world context.
Structure breakdown
The paper is divided into three numbered parts. Part A addresses varicella zoster: a pregnancy case, transmission risks, and six infection control recommendations. Part B covers MRSA: general management, treatment options, and clinical signs. Part C defines and distinguishes key epidemiological terms — incidence, prevalence, endemic, epidemic, and pandemic — using concrete disease examples. Each section follows a question-and-answer sub-structure (a, b, c), suggesting this was written in response to structured assessment prompts.
Varicella Zoster in Pregnancy and Breakthrough Varicella
As standard procedure warranted in this case, the patient's obstetrician injected her with varicella zoster-specific immunoglobulin. Although the injection occurred too late to be fully effective, it was administered as a prophylactic measure to protect the baby. A few days later, the registered nurse (RN) developed chickenpox regardless. The likely reason the vaccine did not take is that she had already been exposed; this situation is referred to as "breakthrough varicella" (National Centre for Immunisation, 2009, p. 3). Breakthrough varicella is a mild form of the infection, yet it remains contagious.
The varicella vaccine should not be given to the infant until it is twelve months of age, though it may not be necessary at all due to potential in utero exposure to the varicella zoster virus (VZV). Infants "should receive no specific treatment or vaccination after exposure to Varicella zoster virus (VZV) but can later receive acyclovir" (Immunization Action Coalition, 2014).
Infection Transmission Risks and Vaccination Considerations
According to the Immunization Action Coalition (2014), "there has been only one published report of mother-to-child transmission of varicella vaccine virus." Moreover, "if the mother is at high risk of exposure to varicella, the benefits of vaccination probably outweigh the risk of transmission to the infant" (Immunization Action Coalition, 2014). If the mother contracts chickenpox during the first half of her pregnancy, there is a small chance the baby will experience serious effects, including scarring and birth defects (Children, Youth, and Women's Health Service, n.d.). The risk is considerably higher when the woman contracts chickenpox closer to the delivery date, which is why vaccination may be administered in these circumstances.
Create your account
Always verify citation format against your institution’s current style guide requirements.